N-4-Benzyloxyphenyl α-benzilidene isobutyrylacetamide

Off-White Solid

A intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hyper